open access

Vol 12, No 1 (2009)
Editorial
Published online: 2009-04-21
Submitted: 2012-01-23
Get Citation

Revolutionary impact of PET and PET-CT on the day-to-day practice of medicine and its great potential for improving future health care

Sandip Basu, Abass Alavi
Nucl. Med. Rev 2009;12(1):1-13.

open access

Vol 12, No 1 (2009)
Editorial
Published online: 2009-04-21
Submitted: 2012-01-23

Abstract

In this communication, we present an overview of the impact and advantages of PET and PET-CT fusion imaging in the practice of medicine. We also discuss the evolution of this promising molecular imaging technique since its inception and the future prospects of the combined structure-function approach. Superior contrast resolution, accurate quantification and above all optimal image quality aid in improved diagnosis of many serious disorders including cancer. We speculate that this powerful imaging approach will almost completely replace most other conventional methods in the future. Currently, 18[F]-fluorode- -oxyglucose (FDG) is the main radiopharmaceutical employed for PET studies around the globe. With the availability of high quality PET images on a routine basis in most centres around the world and the likelihood that several other useful PET tracers will be approved in the near future for routine clinical applications, this technique will likely become essential in almost any medical disorder.

Abstract

In this communication, we present an overview of the impact and advantages of PET and PET-CT fusion imaging in the practice of medicine. We also discuss the evolution of this promising molecular imaging technique since its inception and the future prospects of the combined structure-function approach. Superior contrast resolution, accurate quantification and above all optimal image quality aid in improved diagnosis of many serious disorders including cancer. We speculate that this powerful imaging approach will almost completely replace most other conventional methods in the future. Currently, 18[F]-fluorode- -oxyglucose (FDG) is the main radiopharmaceutical employed for PET studies around the globe. With the availability of high quality PET images on a routine basis in most centres around the world and the likelihood that several other useful PET tracers will be approved in the near future for routine clinical applications, this technique will likely become essential in almost any medical disorder.
Get Citation

Keywords

PET; PET-CT; 18[F]-fluorodeoxyglucose

About this article
Title

Revolutionary impact of PET and PET-CT on the day-to-day practice of medicine and its great potential for improving future health care

Journal

Nuclear Medicine Review

Issue

Vol 12, No 1 (2009)

Article type

Editorial

Pages

1-13

Published online

2009-04-21

Bibliographic record

Nucl. Med. Rev 2009;12(1):1-13.

Keywords

PET
PET-CT
18[F]-fluorodeoxyglucose

Authors

Sandip Basu
Abass Alavi

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl